Skip to main content
S

SCL Science Inc. — Investor Relations & Filings

Ticker · 246960 ISIN · KR7246960009 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2025-08-11 Director's Dealing
Country KR South Korea
Listing KO 246960

About SCL Science Inc.

https://sclscience.com/en

SCL Science Inc., formerly InnoTherapy Inc., is a healthcare company focused on digital innovation and advanced medical technologies. The company develops and commercializes medical hemostatic agents based on its proprietary biomimetic technology, including the Bio-inspired Medical Materials (BiMM) product line. Leveraging 40 years of expertise in medical science, SCL Science is also dedicated to building a digital healthcare ecosystem using artificial intelligence and high-quality medical data. Its services extend to clinical trial analysis, bio-logistics, and an expanding drug discovery platform focused on AI-driven cancer vaccine development. The company serves hospitals, research laboratories, and other medical institutions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). This type of filing is a standard disclosure for insider trading or changes in share ownership by company directors and executives, which corresponds to the 'Director's Dealing' category.
2025-08-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). This is a standard regulatory filing used to disclose insider trading or changes in share ownership by company directors and executives. Based on the provided categories, this fits the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2025-08-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including reasons for changes such as market purchases and bonus share issues. This falls under the 'Major Shareholding Notification' category.
2025-08-11 Korean
주권매매거래정지 (영업양수도)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice regarding the suspension of stock trading for (주)에스씨엘사이언스 due to a business transfer (영업양수도). It cites KOSDAQ market regulations and specifies the duration of the trading halt. Since it is a regulatory announcement regarding market operations and does not fit into specific categories like M&A (TAR) or share issues (SHA), it falls under the general regulatory filing category.
2025-07-28 Korean
주요사항보고서(영업양수결정)
M&A Activity Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding a 'Business Acquisition Decision' (영업양수 결정). It details the acquisition of a business unit, including financial terms, valuation, and payment schedules. In the context of Korean corporate filings, this type of regulatory disclosure regarding significant business transactions (M&A-related activity) is classified under M&A Activity.
2025-07-28 Korean
[기재정정]주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities regarding a 'Bonus Issue' (무상증자). It details the decision to issue new shares, the ratio of the bonus issue, and includes a correction (정정신고) to the listing date. Since this relates to a change in capital structure through a bonus issue (share issuance), it falls under the 'Share Issue/Capital Change' category.
2025-07-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.